Page 9 - Pharma Companies
Regeneron Pharmaceuticals quarterly profit beats on strong drug sales
Regeneron's antibody cocktail garnered $145.5 million in sales for the fourth quarter. While, the consensus Wall Street estimate was $173 million, according to Guggenheim analyst Yatin Suneja.
 "Regeneron Pharmaceuticals quarterly profit beats on strong drug sales")
Pfizer retracts request for emergency approval of Covid-19 vaccine in India
Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine
 "Pfizer retracts request for emergency approval of Covid-19 vaccine in India")
US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end
Frazier, 66, will remain with the drugmaker as executive chairman for a transition period to be determined by the board.
 "US drugmaker Merck's Kenneth Frazier to step down as CEO in June-end")
Novavax Covid-19 vaccine shows 89% efficacy in UK clinical trials
The trial has assessed its efficacy during a period with high transmission and with a new UK strain of the virus
 "Novavax Covid-19 vaccine shows 89% efficacy in UK clinical trials")
World Coronavirus Dispatch: Pharma giants not prepared for next pandemic
World cases cross 100 mn, Italian politics and Dutch protests add to Europe's Covid woes, Japan wants domestic trials before vaccine roll-out and other pandemic-related news across the globe
 "World Coronavirus Dispatch: Pharma giants not prepared for next pandemic")
Serum Institute looking at bilateral deals to supply Covishield vaccine
To raise manufacturing capacity by 30% over next 2 months from present 2.4 mn doses
 "Serum Institute looking at bilateral deals to supply Covishield vaccine")
Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs
NeuroRx and Relief Therapeutics have partnered to develop a drug called RLF-100 that has anti-inflammatory and anti-cytokine activity properties.
 "Dr Reddy's, Zuventus get nod to conduct Covid-19 trials on repurposed drugs")
Firms' next challenge: Handling staff refusing to take Covid-19 vaccine
Top European biz group with representation from top firms to approach govt for guidelines
 "Firms' next challenge: Handling staff refusing to take Covid-19 vaccine")
Wockhardt, IIL discuss manufacturing tie-up with US vaccine major Moderna
Around November, IIL had indicated that it was open to discussions with the US major.
 "Wockhardt, IIL discuss manufacturing tie-up with US vaccine major Moderna")
Three flights carrying coronavirus vaccines land at Delhi airport
Three flights carrying COVID-19 vaccines from Pune and Hyderabad landed at the Delhi airport on Wednesday, its spokesperson said.
 "Three flights carrying coronavirus vaccines land at Delhi airport")
Pharma, healthcare growing, but they face challenges beyond Covid-19
These sectors will face another tough year after coronavirus pandemic, the first challenge being vaccination of India's 1.3 billion people. Devangshu Datta explains the opportunities and threats
 "Pharma, healthcare growing, but they face challenges beyond Covid-19")
Serum Institute may supply around 400 million more doses to Gavi-Covax
Serum Institute already has two deals of 100 million each to supply the Oxford-AstraZeneca and the Novavax vaccine to Gavi-Covax at $3 per dose
 "Serum Institute may supply around 400 million more doses to Gavi-Covax")
What sets Zydus Cadila apart among indigenous players in Covid vaccine race
The company says the stability of the vaccine is one of its biggest advantages amid dry runs of mass vaccination programmes being conducted in some states
 "What sets Zydus Cadila apart among indigenous players in Covid vaccine race")
Brexit to benefit Indian firms only in the long run, say analysts
Auto, pharma, IT, chemicals among sectors with significant reliance on UK and European nations with Tata Motors, Motherson Sumi, Tata Steel, TCS, Wipro, Infosys and Tech M among key names
 "Brexit to benefit Indian firms only in the long run, say analysts")
USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
Biocon said its arm, Biocon Biologics, and Mylan have been informed by the USFDA of a deferred action on the biologics license application for a biosimilar to drug Avastin
 "USFDA informs Biocon, Mylan of deferred action on biosimilar license plea")
Centre may not procure Pfizer-BioNTech Covid vaccine over high cost
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield
 "Centre may not procure Pfizer-BioNTech Covid vaccine over high cost")
Cipla settles blood cancer drug litigation with Bristol Myers in US
As it takes away the legal overhang, Cipla can launch the drug once its ANDA is approved
 "Cipla settles blood cancer drug litigation with Bristol Myers in US")
Pfizer working on cold storage issues to ensure temperature integrity
The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring.
 "Pfizer working on cold storage issues to ensure temperature integrity")
Pfizer, BioNtech in final stages of talks with WHO to join Covax alliance
The ultra-cold chain requirement of Pfizer's vaccine, unlike most other vaccines, makes it a challenge for most countries including India to store and transport
 "Pfizer, BioNtech in final stages of talks with WHO to join Covax alliance")
Singapore-based Everstone buys controlling stake in Calibre for Rs 1,000 cr
Singapore-headquartered, India-focused PE firm Everstone Capital bought a controlling stake in Calibre, a specialty ingredients player focused on pharma, in a reported Rs 1,000-crore deal
 "Singapore-based Everstone buys controlling stake in Calibre for Rs 1,000 cr")
